The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT06203275 · UNKNOWN
Trial details
- NCT number
- NCT06203275
- Sponsor
- aya ramadan ashmawy sarhan
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-01
- Primary completion
- 2025-01-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.